Association of neutrophil percentage-to-albumin ratio with all-cause and respiratory disease-related mortality in US adults with asthma

美国哮喘成人中性粒细胞百分比与白蛋白比值与全因死亡率和呼吸系统疾病相关死亡率的关系

阅读:2

Abstract

BACKGROUND: Systemic inflammation and immune dysregulation may be associated with asthma onset and progression. Neutrophil percentage-to-albumin ratio (NPAR) is a novel marker of systemic inflammation. We aimed to investigate the association of NPAR with all-cause and respiratory disease-related mortality in adults with asthma. METHODS: This is a retrospective cohort study using data from 5032 participants with asthma from the National Health and Nutrition (NHANES) spanning from 1999 to 2018. NPAR was calculated by neutrophil percentage (% of total white blood cell count) × 100/serum albumin (g/dl). Asthma was self-reported based on responses to a standardized questionnaire in NHANES. Mortality data were obtained through retrospective matching with the National Death Index (NDI), using secondary data from NHANES. Survey-weighted multivariable Cox proportional hazards regression analysis was used to explore these associations. RESULTS: After a median follow-up duration of 104 months, 696 participants died, of which 101 were respiratory disease-related deaths. In fully adjusted models, NPAR was significantly and positively associated with both all-cause and respiratory disease-related mortality (hazard ratios [HR] of 1.13 and 1.25, respectively, both p < 0.0001). Compared to Q1, NPAR at Q4 was associated with significantly increased all-cause and respiratory disease-related mortality (all-cause: HR 2.23, p < 0.0001; respiratory disease-related: HR 3.55, p = 0.004). NPAR was nonlinearly associated with all-cause mortality, with an inflection point of 13.76. This association was significant only after the inflection point (HR 1.18, p < 0.0001). The effect of NPAR on all-cause mortality was more pronounced in those < 60 years of age (HR 1.19, p < 0.0001). CONCLUSIONS: Higher NPAR was associated with increased all-cause and respiratory disease-related mortality in US adults with asthma. Further exploration of the prognostic potential and underlying mechanisms of NPAR is needed. CLINICAL TRIAL NUMBER: Not applicable.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。